These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23761146)

  • 1. Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations.
    Rigouts L; Gumusboga M; de Rijk WB; Nduwamahoro E; Uwizeye C; de Jong B; Van Deun A
    J Clin Microbiol; 2013 Aug; 51(8):2641-5. PubMed ID: 23761146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed
    Wang W; Liu R; Yao C; Huo F; Shang Y; Zhang X; Wang Y; Xue Z; Ma L; Pang Y
    Microbiol Spectr; 2022 Feb; 10(1):e0208721. PubMed ID: 35107324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampin drug resistance tests for tuberculosis: challenging the gold standard.
    Van Deun A; Aung KJ; Bola V; Lebeke R; Hossain MA; de Rijk WB; Rigouts L; Gumusboga A; Torrea G; de Jong BC
    J Clin Microbiol; 2013 Aug; 51(8):2633-40. PubMed ID: 23761144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results.
    Van Deun A; Barrera L; Bastian I; Fattorini L; Hoffmann H; Kam KM; Rigouts L; Rüsch-Gerdes S; Wright A
    J Clin Microbiol; 2009 Nov; 47(11):3501-6. PubMed ID: 19759221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of rpoB mutations in isoniazid-resistant but rifampin-susceptible Mycobacterium tuberculosis isolates from Germany.
    Andres S; Hillemann D; Rüsch-Gerdes S; Richter E
    Antimicrob Agents Chemother; 2014; 58(1):590-2. PubMed ID: 24145520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results.
    Ocheretina O; Escuyer VE; Mabou MM; Royal-Mardi G; Collins S; Vilbrun SC; Pape JW; Fitzgerald DW
    PLoS One; 2014; 9(3):e90569. PubMed ID: 24599230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Disputed Mutations in the
    Miotto P; Cabibbe AM; Borroni E; Degano M; Cirillo DM
    J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29540456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advantages of the AdvanSure MDR-TB GenoBlot assay containing disputed rpoB mutation-specific probes in a routine clinical laboratory setting.
    Yoo IY; Huh HJ; Kang OK; Jhun BW; Koh WJ; Lee NY
    Respir Med; 2019 Jan; 146():71-75. PubMed ID: 30665521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Mutations Conferring Resistance to Rifampin in Mycobacterium tuberculosis Clinical Strains.
    Jagielski T; Bakuła Z; Brzostek A; Minias A; Stachowiak R; Kalita J; Napiórkowska A; Augustynowicz-Kopeć E; Żaczek A; Vasiliauskiene E; Bielecki J; Dziadek J
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis.
    Rahman A; Sahrin M; Afrin S; Earley K; Ahmed S; Rahman SM; Banu S
    PLoS One; 2016; 11(4):e0152694. PubMed ID: 27054344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance Evaluation of the BACTEC MGIT 960 System for Rifampin Drug-Susceptibility Testing of Mycobacterium tuberculosis Using the Current WHO Critical Concentration.
    Yu HJ; Kim TY; Kim G; Shim HJ; Kang OK; Kim S; Kim CK; Jhun BW; Lee NY; Huh HJ; Lee HJ
    J Clin Microbiol; 2023 Jan; 61(1):e0108622. PubMed ID: 36602360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated liquid culture system misses isoniazid heteroresistance in Mycobacterium tuberculosis isolates with mutations in the promoter region of the inhA gene.
    Zhang Z; Lu J; Wang Y; Pang Y; Zhao Y
    Eur J Clin Microbiol Infect Dis; 2015 Mar; 34(3):555-60. PubMed ID: 25344830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Level Rifampin Resistance and
    Shea J; Halse TA; Kohlerschmidt D; Lapierre P; Modestil HA; Kearns CH; Dworkin FF; Rakeman JL; Escuyer V; Musser KA
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 32999007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of
    Tavanaee Sani A; Ashna H; Kaffash A; Khaledi A; Ghazvini K
    Ethiop J Health Sci; 2018 May; 28(3):299-304. PubMed ID: 29983529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin.
    Zaczek A; Brzostek A; Augustynowicz-Kopec E; Zwolska Z; Dziadek J
    BMC Microbiol; 2009 Jan; 9():10. PubMed ID: 19146699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.
    Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
    BMC Infect Dis; 2012 Feb; 12():37. PubMed ID: 22325147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of hybridization with the wild-type and mutant rpoB probes in the Genotype MTBDRplus assay detects 'disputed' rifampicin mutations.
    Abanda NN; Djieugoué JY; Khadka VS; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Deng Y; Eyangoh SI; Taylor DW; Leke RGF
    Clin Microbiol Infect; 2018 Jul; 24(7):781.e1-781.e3. PubMed ID: 29217277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampin-resistance-associated mutations in the rifampin-resistance-determining region of the
    Guo Y; Cao X; Yang J; Wu X; Liu Y; Wan B; Hu L; Wang H; Yu F
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33507146
    [No Abstract]   [Full Text] [Related]  

  • 20. Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.
    Ocheretina O; Shen L; Escuyer VE; Mabou MM; Royal-Mardi G; Collins SE; Pape JW; Fitzgerald DW
    PLoS One; 2015; 10(6):e0129207. PubMed ID: 26039194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.